24 results
S-3
LTRN
Lantern Pharma Inc
2 Jul 21
Shelf registration
4:15pm
of shares of common stock have no preemptive, conversion, subscription or cumulative voting rights.
This prospectus provides a general description … , or how it will be calculated, and the exchange period;
voting rights, if any, of the preferred stock;
preemptive rights, if any;
restrictions
10-K
omzhjd0a4gekp6goxub
10 Mar 21
Annual report
4:07pm
10-K
EX-4.3
ir49d2f
10 Mar 21
Annual report
4:07pm
424B4
moht7a
15 Jan 21
Prospectus supplement with pricing info
5:24pm
DRS
l0qnop8abo
16 Dec 20
Draft registration statement
12:00am
8-K
EX-99.1
dn2lta
21 Aug 20
Departure of Directors or Certain Officers
6:31am
424B4
jqcj8y
12 Jun 20
Prospectus supplement with pricing info
7:49am
S-1
EX-10.8
v49 9bkhhyl5gt5lcq2
16 Apr 20
IPO registration
3:32pm
S-1
5jtda26b6 sok9n5lnv
16 Apr 20
IPO registration
3:32pm
S-1
EX-3.1
faxtgob
16 Apr 20
IPO registration
3:32pm
S-1
EX-10.1
8ki5tmnjj6fv
16 Apr 20
IPO registration
3:32pm